How generalizable are the results of large randomized controlled trials of antiretroviral therapy?

HIV Medicine

Volumn 1, Issue 3, 2000, Pages 149-154

  Moore, Daj ^a,b   Goodall, R L ^a   Ives, N J ^a   Hooker, M ^a   Gazzard, B G ^a   Easterbrook, P J ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

Author keywords

Clinical trials; Generalizability; HIV

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; EPIDEMIOLOGY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; PATIENT SELECTION; RANDOMIZED CONTROLLED TRIAL; REPRODUCIBILITY; STANDARD;

ADULT; ANTI-HIV AGENTS; FEMALE; HIV INFECTIONS; HUMANS; MALE; PATIENT SELECTION; RANDOMIZED CONTROLLED TRIALS; REPRODUCIBILITY OF RESULTS; SELECTION BIAS;

EID: 0034232621     PISSN: 14642662     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-1293.2000.00019.x     Document Type: Article

References (19)

1. Rosenberg WM, Sackett DL. On the need for evidence-based medicine. Therapie 1996; 51: 212-217.
2. Sackett DL, Haynes BR, Tugwell P. Early diagnosis. In: Clinical Epidemiology. A basic science for clinical medicine. Little Brown, 1986: 146-148.
3. Spilker B. Extrapolation of data. In: Guide to Clinical Interpretation of Data. Chapter 23. Raven Press, 1986: 249-258.
4. Licht RW, Gouliaev G, Vestergaard P, Frydenberg M. Generalisability of results from randomised drug trials. A trial on antimanic treatment. Br J Psychiatry 1997; 170: 264-267.
5. Brown N, Melville M, Gray D, etal. Relevance of clinical trial results in myocardial infarction to medical practice: comparison of four year outcome in participants of a thrombolytic trial, patients receiving routine thrombolysis, and those deemed ineligible for thrombolysis. Heart 1999; 81: 598-560.
6. Morris-Jones S, Moyle G, Easterbrook PJ. Antiretroviral therapies in HIV-1 infection. Exp Opin Invest Drugs 1997; 6: 1048-1061.
7. Concorde Coordinating Committee. Concorde: MRC/ANRS randomized double-blind controlled trial of immediate versus deferred zidovudine in symptom-free HIV infection. Lancet 1994; 343: 871-881.
8. Delta Coordinating Committee. Delta: a randomised doubleblind controlled trial comparing combinations of zidovudine plus didanosine or zalcitabine with zidovudine alone in HIV-infected individuals. Lancet 1996; 348: 283-291.
9. Altman DG. Practical Statistics for Medical Research. London, Chapman ÖHall, 1991.
10. Carlson RW, Tu SW, Lane NM, et al Computer based screening of patients with HIV/AIDS for clinical trial eligibility. Online Journal of Current Clinical Trials, doc no. 179. 1995.
11. Montaner JS, Hogg R, Srour LF, et al. Should we embrace new drugs with open arms? Experience from a community-based, open-arm, randomized clinical trial of combination antiretroviral therapy in advanced HIV disease. J AIDS 1996; 13: 422-426.
12. Taylor KM, Margolese RG, Soskoline CL. Physicians' reasons for not entering patients in a randomised clinical trial of surgery for breast cancer. N EnglJMed 1984;310: 1363-1367.
13. Samet JH, Retondo MJ, Freedberg KA, Stein MD, Heeren T, Libman H. Factors associated with initiation of primary medical care for HIV-infected persons. Am J Med 1994; 97: 347-353.
14. AIDS and HIV infection in the United Kingdom: monthly report. HIV infection acquired through sex between men Commun Dis Rep 1999; 9: 121-122.
15. AIDS and HIV infection in the United Kingdom: monthly report. Commun Dis Rep 1999; 9: 199-200.
16. El-Sadr W, Capps L. The challenge of minority recruitment in clinical trials for AIDS. J Am Med Assoc 1992; 267: 954-957.
17. Galai N, Vlahov D, Margolick JB, Chen K, Graham NM, Munoz A. Changes in markers of disease progression in HIV-1 seroconverters: a comparison between cohorts of injecting drug users and homosexual men. J AIDS 1995; 8: 66-74.
18. Bugeja G, Kumar A, Banerjee AK. Exclusion of elderly people from clinical research. A descriptive study of published reports. Br Med J 1997; 315: 1059.
19. Begg C, Cho M, Eastwood S, étal. Improving the quality of reporting of randomized controlled trials. The CONSORT statement. J Am Med Assoc 1996; 276: 637-639.